University of Calgary’s 4D Digital Twin Technology Doubles Heart Function Improvement in Cardiac Patients

University of Calgary's MAPIT-CRT trial shows 4D digital twins double heart function improvement for patients receiving specialized pacemakers.

By: AXL Media

Published: Mar 25, 2026, 5:53 AM EDT

Source: Information for this report was sourced from University of Calgary

The Emergence of Personalized Digital Cardiology

The integration of advanced computational modeling into clinical practice is redefining the standard of care for chronic heart failure. Developed at the University of Calgary, a new 4D heart model creates a patient-specific digital replica, or "digital twin," using data derived from cardiac MRI images. This technology allows clinicians to visualize a "beating" representation of a patient’s unique anatomy, providing a sophisticated roadmap for complex interventions that were previously guided by generalized statistical models.

Optimizing Cardiac Resynchronization Therapy Delivery

The primary application of this 4D technology involves guiding the placement of specialized pacemakers, a process known as cardiac resynchronization therapy (CRT). The goal of CRT is to coordinate the squeezing motion of the heart walls to ensure efficient blood flow, yet traditional methods see a non-response rate of up to one-third of patients. By using the virtual model to target treatment, surgeons can precisely identify the optimal location for pacemaker leads, directly addressing the anatomical variability that often leads to suboptimal results in conventional procedures.

Clinical Validation Through the MAPIT-CRT Trial

The efficacy of the digital twin approach was rigorously tested in the MAPIT-CRT national clinical trial, which enrolled 202 patients across seven Canadian centers. According to the findings published in Circulation: Arrhythmia and Electrophysiology, 66 percent of patients receiving model-guided therapy showed significant improvement, compared to only 52 percent in the control group. Dr. James White, the study's senior author, noted that the trial was specifically designed to move digital heart models from theoretical computer simulations into real-world clinical environments with measurable patient benefits.